Results 271 to 280 of about 2,603,502 (346)

Financial Integration, Specialization, and Systemic Risk [PDF]

open access: green, 2007
Falko Fecht   +2 more
openalex   +1 more source

A Bio‐Inspired Perspective on Materials Sustainability

open access: yesAdvanced Materials, EarlyView.
This perspective discusses natural materials as inspiration for sustainable engineering designs and the processing of materials. First, circularity, longevity, parsimony, and activity are presented as essential material paradigms. The perspective then uses many examples of natural and technical materials to introduce principles such as oligo ...
Wolfgang Wagermaier   +2 more
wiley   +1 more source

ADVANTAGES AND LIMITS OF SYSTEMIC HEPARIN-FREE HEMODIALYSIS IN PATIENTS AT RISK OF BLEEDING USING THE AN69-ST MEMBRANE

open access: bronze, 2004
S. Lavaud   +6 more
openalex   +1 more source

Treatment of ichthyosiform diseases with topically applied tazarotene: Risk of systemic absorption [PDF]

open access: bronze, 2007
Victoria Nguyen   +4 more
openalex   +1 more source

From Molecule to Aggregate: Designing AIE Nanocrystals for Low‐Power Backward Third‐Harmonic Generation Angiography

open access: yesAdvanced Materials, EarlyView.
An organic BTHG agent called OTBP with prominent crystallinity is developed. The resonant absorption at 433 nm and prominent crystallinity of OTBP enhance its BTHG efficiency when excited by a 1300 nm femtosecond laser. Tuning the size of OTBP nanocrystals based on Mie scattering theory successfully enables them to achieve high‐contrast muti‐organ ...
Lidong Du   +12 more
wiley   +1 more source

Systemic Risk and Hedge Funds

open access: bronze, 2005
Nicholas Chan   +3 more
openalex   +1 more source

Engineering CAR‐T Therapeutics for Enhanced Solid Tumor Targeting

open access: yesAdvanced Materials, EarlyView.
CART cell therapy has proven effective for blood cancers but struggles with solid tumors due to diverse antigens and complex environments. Recent efforts focus on improving CAR design and validation platforms. Advances in protein engineering, machine learning, and organoid systems aim to enhance CAR‐T therapy against solid tumors.
Danqing Zhu   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy